Parallax Volatility Advisers, L.P. Immatics N.V. Transaction History
Parallax Volatility Advisers, L.P.
- $53.5 Billion
- Q3 2024
A detailed history of Parallax Volatility Advisers, L.P. transactions in Immatics N.V. stock. As of the latest transaction made, Parallax Volatility Advisers, L.P. holds 10,000 shares of IMTX stock, worth $53,500. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$53,500% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding IMTX
# of Institutions
101Shares Held
75.8MCall Options Held
238KPut Options Held
727K-
Rtw Investments, LP New York, NY10MShares$53.5 Million1.82% of portfolio
-
Wellington Management Group LLP Boston, MA9.68MShares$51.8 Million0.02% of portfolio
-
Perceptive Advisors LLC New York, NY8.09MShares$43.3 Million2.41% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.38MShares$39.5 Million0.05% of portfolio
-
Baker Bros. Advisors LP New York, NY6.44MShares$34.5 Million0.79% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $408M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...